Access to this article is restricted until 12 months after publication by request of the publisher. Restriction lift date: 2025-06-27
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
dc.check.date | 2025-06-27 | en |
dc.check.info | Access to this article is restricted until 12 months after publication by request of the publisher | en |
dc.contributor.author | Pappa, Christina | en |
dc.contributor.author | Galaal, Khadra | en |
dc.contributor.author | Smyth, Sarah | en |
dc.contributor.author | Bristow, Robert E. | en |
dc.contributor.author | Khashan, Ali S. | en |
dc.contributor.author | Alazzam, Mo'iad | en |
dc.date.accessioned | 2024-07-11T13:26:00Z | |
dc.date.available | 2024-07-11T13:26:00Z | |
dc.date.issued | 2024-06-27T00:00:00Z | en |
dc.description.abstract | This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer. | en |
dc.description.status | Not peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | CD015297 | en |
dc.identifier.citation | Pappa, C., Galaal, K., Smyth, S., Bristow, R. E., Khashan, A. S. and Alazzam, M. (2024) 'Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer', Cochrane Database of Systematic Reviews 2024, Issue 6, CD015297 (15pp). https://doi.org/10.1002/14651858.CD015297 (Accessed: 11 July 2024) | en |
dc.identifier.doi | https://doi.org/10.1002/14651858.CD015297 | en |
dc.identifier.eissn | 1469-493X | en |
dc.identifier.endpage | 15 | en |
dc.identifier.issued | 6 | en |
dc.identifier.journaltitle | Cochrane Database of Systematic Reviews | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/16117 | |
dc.identifier.volume | 2024 | en |
dc.language.iso | en | en |
dc.publisher | John Wiley & Sons, Inc. | en |
dc.rights | © 2024, The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. | en |
dc.subject | Cytoreductive surgery plus chemotherapy | en |
dc.subject | Chemotherapy alone | en |
dc.subject | Recurrent epithelial ovarian cancer | en |
dc.title | Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer | en |
dc.type | Other | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Pappa_et_al-2024-Cochrane_Database_of_Systematic_Reviews.pdf
- Size:
- 231.57 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: